XML 81 R69.htm IDEA: XBRL DOCUMENT
v3.25.1

Stockholders’ Deficit - Schedule of common stock issuable upon exercise of warrants outstanding (Details) | 3 Months Ended
--- | ---
Mar. 31, 2025 $ / shares shares
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 3,087,116
Warrants exercised (in shares) | 0
Number of Warrants Cancelled (in shares) | 472,500
Number of Warrants Exercisable (in shares) | 2,614,616
Public Warrants |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 7,188
Warrants exercised (in shares) | 0
Number of Warrants Cancelled (in shares) | 0
Number of Warrants Exercisable (in shares) | 7,188
Exercise price (in dollars per share) | $ / shares | $ 4,600
Private Warrants - February 2020 |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 341
Warrants exercised (in shares) | 0
Number of Warrants Cancelled (in shares) | 0
Number of Warrants Exercisable (in shares) | 341
Exercise price (in dollars per share) | $ / shares | $ 4,600
PIPE Warrants |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 3,384
Warrants exercised (in shares) | 0
Number of Warrants Cancelled (in shares) | 0
Number of Warrants Exercisable (in shares) | 3,384
Exercise price (in dollars per share) | $ / shares | $ 4,600
2022 July Institutional/Accredited Investor Warrants |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 10,000
Warrants exercised (in shares) | 0
Number of Warrants Cancelled (in shares) | 0
Number of Warrants Exercisable (in shares) | 10,000
Exercise price (in dollars per share) | $ / shares | $ 1,500
Underwriter Warrants - February 2024 offering |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 48,000
Warrants exercised (in shares) | 0
Number of Warrants Cancelled (in shares) | 22,500
Number of Warrants Exercisable (in shares) | 25,500
Exercise price (in dollars per share) | $ / shares | $ 20.00
2024 February Institutional/Accredited Investor Warrants - series A |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 480,000
Warrants exercised (in shares) | 0
Number of Warrants Cancelled (in shares) | 0
Number of Warrants Exercisable (in shares) | 480,000
Exercise price (in dollars per share) | $ / shares | $ 20.00
2024 February Institutional/Accredited Investor Warrants - series C |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 480,000
Warrants exercised (in shares) | 0
Number of Warrants Cancelled (in shares) | 450,000
Number of Warrants Exercisable (in shares) | 30,000
Exercise price (in dollars per share) | $ / shares | $ 20.00
2024 October Institutional/Accredited Investor Warrants |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 1,147,832
Warrants exercised (in shares) | 0
Number of Warrants Cancelled (in shares) | 0
Number of Warrants Exercisable (in shares) | 1,147,832
Exercise price (in dollars per share) | $ / shares | $ 3.78
2024 December Institutional/Accredited Investor Warrants |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 85,287
Warrants exercised (in shares) | 0
Number of Warrants Cancelled (in shares) | 0
Number of Warrants Exercisable (in shares) | 85,287
Exercise price (in dollars per share) | $ / shares | $ 3.26
2025 March Institutional/Accredited Investor Warrants |
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items] |
Number of Warrants (in shares) | 825,084
Warrants exercised (in shares) | 0
Number of Warrants Cancelled (in shares) | 0
Number of Warrants Exercisable (in shares) | 825,084
Exercise price (in dollars per share) | $ / shares | $ 2.02

X
- Definition Class of Warrant or Right, Exercisable + References No definition available. + Details
Name: | nvve_ClassOfWarrantOrRightExercisable
Namespace Prefix: | nvve_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Class of Warrant or Right, Exercised + References No definition available. + Details
Name: | nvve_ClassOfWarrantOrRightExercised
Namespace Prefix: | nvve_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number Of Warrants Cancelled + References No definition available. + Details
Name: | nvve_NumberOfWarrantsCancelled
Namespace Prefix: | nvve_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvve_StockholdersEquityDetailsScheduleofcommonstockissuableuponexerciseofwarrantsoutstandingLineItems
Namespace Prefix: | nvve_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of increase (decrease) in shares of stock classified as other. + References No definition available. + Details
Name: | us-gaap_StockholdersEquityOtherShares
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_PublicWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_PrivateWarrantsFebruary2020Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_PIPEWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_July2022InstitutionalAccreditedInvestorWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_UnderwriterWarrantsFebruary2024OfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_February2024InstitutionalAccreditedInvestorWarrantsSeriesAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_February2024InstitutionalAccreditedInvestorWarrantsSeriesCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_October2024InstitutionalAccreditedInvestorWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_December2024InstitutionalAccreditedInvestorWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=nvve_A2025MarchInstitutionalAccreditedInvestorWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |